Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming a significant proportion of public health spending. Oral hypoglycemic agents (OHAs) are the frontline treatment approaches after lifestyle changes. However, huge interindividual variation in response to OHAs results i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawed, Adem Yesuf, Zhou, Kaixin, Pearson, Ewan Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827904/
https://www.ncbi.nlm.nih.gov/pubmed/27103840
http://dx.doi.org/10.2147/PGPM.S84854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827904/
https://www.ncbi.nlm.nih.gov/pubmed/27103840
http://dx.doi.org/10.2147/PGPM.S84854

Ejemplares similares